KDO ALDOLASE AND CONDENSATION REACTIONS EMPLOYED THEREWITH

Abstract: Aureobacterium barkerei strain KDO-37-2 (ATCC 49977) KDO aldolase (EC 4.1.2.23) isolated therefrom are disclosed. The DKDO aldolase is further disclosed to have a broad substrate specificity with respect to its reverse reaction, i.e. the condensation of aldoses with pyruvate to form a wide range of 2-keto-3-deoxy-onic acids, including 2-keto-3-deoxy-nonulosonic acid, 2-keto-3-deoxy-octulosonic acid, 2-keto-3-deoxy-heptulosonic acid, and 2-keto-3-deoxy-hexulosonic acid. In particular, 3-deoxy-D-manno-2-octulosonic acid (D-KDO), a vital component of lipopolysaccharides found in the bacterial outer membrane may be synthesized from D-arabinose and pyruvate in 67 % yield. Additionally, protected forms of the KDO aldolase products, e.g. hexaacetyl 2-keto-3-deoxy-nonulosonic acid and pentaacetyl 2-keto-3-deoxy-octulosonic acid, may be decarboxylated to form the corresponding 2-deoxy-aldoses, e.g. 2-deoxy-octulose and 2-deoxy-heptulose respectively.

Description: KDO ALDOLASE AND CONDENSATION REACTIONS EMPLOYED THEREWITH Description Technical Field The invention relates to KDO aldolase (EC 4.1.2.23) having a broad substrate specificity with respect to its reverse reaction and to condensation reactions employing such KDO aldolase for synthesizing a broad range of 6-9 carbon 2-keto-3-deoxy-onic acids, viz. 2-keto-3-deoxy-hexulosonate, 2-keto-3-deoxy- heptulosonate, 2-keto-3-deoxy-octulosonate, and 2-keto- 3-deoxy-nonuloεonate. More particularly, the invention relates to A reobacterium barkerei strain KDO-37-2 (ATCC 49977) , to KDO aldolase produced by and isolated from such bacteria, to the employment of such KDO aldlose with respect to the synthesis of 2-keto-3-deoxy-onic acids such as 3-deoxy-D-77?ø/7/?ø-2-octuloεonic acid (D-KDO) and to the use of protected forms of such 2-keto-3- deoxy-onic acids for the production of 7 and 8 carbon aldoses by means of radical mediated decarboxylation. Background of the Invention 2-Keto-3-deoxy-octulosonic acid (KDO) appears as a ketoεidic component of all Gram-negative bacteria for which a KDO determination has been made. More particularly, 3-deoxy-D-.ma.n_no- 2-octulosonic acid (D-KDO) is widely found in Gram-negative bacteria. KDO is incorporated into lipopolysaccharides and is localized, as such, within the outer membrane compartment of Gram-negative bacteria. KDO appears to be a vital component of Gram-negative bacteria. KDO can also occur as an acidic exopolysaccharide. IBSTITUT (RULE 26) - 2 - KDO-S-P syntheiasc K O-8-P phosphatase D-arabinose CMP-KDO KDO transferase syntheuisε lipid A-KDO CMP-KDO <\ Lipid A precursor PPi CTP Lipopolysaccharide in Gram-negative bacteria Scheme I In such instances, the KDO can serve as part of a K- antigen. As illuεtrated in Scheme I, the bioεynthetic incorporation of KDO into lipopolysaccharides conεiεts of two steps, i.e.: 1. Activation of KDO to form CMP-KDO by means of CMP-KDO εynthetase (EC 2.7.7.38); and then 2. Coupling of the activated CMP-KDO to lipid A precursor to form lipid A-KDO by means of KDO transferase. The rate-limiting εtep with respect to the biosynthesiε of KDO containing lipopolyεaccharideε is the activation of the KDO moiety, i.e., the formation of CMP-KDO. Accordingly, inhibitors of CMP-KDO εynthetase are potentially useful aε antibacterial agents. Several chemical and enzymatic synthetic routes have been developed for the synthesis of KDO and its analogs. One route for the chemical synthesis of KDO employs Cornforth's method. (Ghalambor, M. et al. J. Biol . Che . 1966, 241 , 3207 and Hershberger, C. et al. J. Biol . Chem . 1968, 243 , 1585.) The chemical εyntheεis of KDO produces multiple enantiomers. In order to obtain enantiomerically pure D-KDO, a εeparation εtep muεt be incorporated into the chemical synthetic route. Synthetic routes employing enzymes are more εtereoεpecific than chemical εynthetic routeε. An enzymatic εynthetic route employing KDO-8 phoεphate εynthase and KDO-8-P phosphatase as catalysts and arabinose-5-P and PEP as substrateε is illustrated in Scheme I. (Bednarski, M. et al. Tetrahedron Letters 1988, 29 , 427.) An alternative enzymatic synthetic route employs sialic acid aldolase. (Auge, C. et al. Tetrahedron 1990, 46 , 201.) An enzymatic εynthetic route employing the reverse reaction of KDO aldolase for a icromolar scale εynthesiε of KDO is diεcloεed by Ghalambor. (Ghalambor, M. et al., J. Biol. Chem . 1966, 242, 3222.) The εynthetic route deεcribed by Ghalambor employs KDO aldolase isolated from Aerobacter cloacae . The reverse reaction of KDO aldolase is driven by employing high substrate levels, i.e. high concentrations of D- arabinose and D-pyruvate. Ghalambor discloseε that there iε a 41% yield with this enzyme and narrow substrate εpecificity. KDO aldolaεe (EC 4.1.2.23) iε known to be inductively produced by εeveral bacteria, viz. Eεcherichia coli, strains 0111, B, and K-12, Salmonella typhimurium, Salmonella aldelaide, and Aerobacter cloacae . Ghalambor discloεeε that all of theεe known KDO aldolaεes have comparable activities. For example, all of these KDO aldolaεes hydrolyze 3-deoxy-D-jnanno-2-octulosonic acid to form D-arabinose and pyruvate in a forward reaction. As indicated above, Ghalambor also discloses that known KDO aldolase may be employed in a reverse reaction to condenεe D- arabinose and pyruvate to form 3-deoxy- D-manno-2-octuloεonic acid. The substrate εpecificity of known KDO aldolases with reεpect to thiε reverεe reaction iε confined to D-arabinose and has been εpecifically shown to lack a measurable specificity for D-ribose in connection with thiε reverse reaction. What was needed was an enzymic synthetic route for the production of a wide range of 2-keto-3-deoxy-onic acids and analogs thereof potentially having activity as inhibitors of CMP-KDO synthetase. What was also needed was a method of converting 2- keto-3-deoxy-onic acids to high-carbon 2-deoxy aldoseε. TTUTE SHEET (RULE 26) Summary of the Invention Aureobacterium barkerei strain KDO-37-2 (ATCC 4 9977) and KDO aldolase (EC 4.1.2.23) isolated therefrom are discloεed therein. KDO aldolaεe catalyzed condenεation employing thiε enzyme haε been de onεtrated to be effective for the εynthesis of KDO and analogs. The reactions are stereospecific with formation of a new _ -εtereocenter at C-3 from D-arabinoεe and related εubεtrateε. Decarboxylation of the aldolase products provideε a new route to heptose and octose derivatives. Unlike known KDO aldolaseε which have a narrow εubεtrate specificity, the KDO aldolase isolated from this source iε diεcloεed to have a very wide substrate specificity with respect to catalyzing its reverse reaction, i.e. the condensation of aldoses with pyruvate. In particular, 3-deoxy-D-jna_n.no- 2-octulosonic acid (D-KDO) can be synthesized from D-arabinose and pyruvate in 67% yield. Furthermore, εtudieε with respect to the εubεtrate specificity of the enzyme using more than 20 natural and unnatural sugars indicate that this enzyme widely accepts trioεeε, tetroses, pentoseε and hexoεeε as subεtrateε, eεpecially the oneε with R configuration at 3 poεition. The substituent on 2 position has little effect on the aldol reaction. Nine of these subεtrateε are submitted to the aldol reaction to prepare various 2-keto-3- deoxy-onic acids, including D-KDO, 3-deoxy- D-ara_bino-2 -heptu1osonic acid (D-DAH) , 2-keto-3-deoxy-L-gluconic acid (L-KDG) , and 3-deoxy-L-o;lycero- L-galacto-nonulosonic acid (L-KDN) . The attack of pyruvate appearε to take place on the re face of the carbonyl group of acceptor εubεtrateε, a facial selection complementary to sialic acid aldolaεe (si face attack) reactions. The aldolase products can be converted to aldoεes via radical-mediated decarboxylation. For example, decarboxylation of pentaacetyl KDO and hexaacetyl neuraminic acid giveε penta-0-acetyl-2-deoxy- / 9 , 3-D-_man_no-heptose and penta-0-acetyl-4-acetamido-2,4-dideoxy-^-D-g2ycero-D- galacto-octoεe, respectively. Brief Description of Drawings Figure 1 illustrates saccharideε having good εpecificity for KDO aldolaεe isolated from Aureobacterium barkerei KDO-37-2. Figure 2 illustrates saccharideε having fair εpecificity for KDO aldolaεe iεolated from Aureobacterium barkerei KDO-37-2. Figure 3 illuεtrateε εaccharideε having poor εpecificity for KDO aldolase isolated from Aureojbacterium jbarλerei KDO-37-2. Figure 4 illustrates the stereochemistry of the aldol condenεation catalyzed by KDO aldolaεe isolated from AureoJbacteriujn barkerei KDO-37-2. Figure 5 illustrates the l E NMR spectrum of 6, the product from 2-deoxy-D-riboεe (400 MHz) , CDC1 3 . Figure 6 illuεtrateε the chemical aεεignment of the ] H NMR spectrum compound 6 as shown in Fig. 6. Detailed Deεcrj-ption A new source of KDO aldolase Aureobacterium barkerei εtrain KDO-37-2 (ATCC 49977) waε iεolated from garden soil using KDO as a major carbon source. The microorganism (strain KDO-37-2) grows well on LB medium. It is aerobic, gra -poεitive, not motile and with colonies 1-3 millimeters in diameter on LB agar plates. The colony morphology iε circular, low convex, entire edge and produces yellow pigment. Optimum growth temperature is about 30°C. Major fatty acids are anteiso-Cι 5:0 and anteiso-C π . 0 . The strain waε identified aε Aureobacterium barkerei according to Bergey'ε manual. A deposit of Aureobacterium barkerei strain KDO-37-2 waε made July 30, 1992 with the American Tyupe Culture Collection (ATCC) 12301 Parklawn Drive, Rockville, Maryland, USA 20852 and waε given Accession Number ATCC 49977. The deposit with accession Number ATCC 49977 was made in compliance with the Budapest Treaty requirements that the duration of the depositε εhould be for 30 years from the date of deposit at the depository or for the enforceable life of a U.S. patent that matureε from this application, whichever is longer. The cell line will be replenished should it become non-viable at the depository. A preferred medium for KDO aldolase production iε defined aε followε: NH 4 C1 (5 gramε) , K 2 S0 4 (l gram)-, MgS0 4 - 7H 2 0 (200 milligrams), CaCl 2 (20 milligrams), FeS0 4 - 7H 2 0 (1 milligram), yeaεt extract (1 gram), Na 2 HP0 4 - 7H 2 0 and KH 2 P0 4 (3 grams) in distilled water (1 liter) at pH 7.2. A seed culture may be made by admixing in a 100 illiliter Erlenmeyer flask 50 milliliters of the above medium together with 25 microliterε of a 40% glucose solution and 100 milligrams (0.2%) of KDO. The seed culture is then inoculated with a loopful of Aureobacterium barkerei strain KDO-37-2 (ATCC 49977). The flask iε then εhaken at 250 r.p.m. on a gyrorotory shaker at 30 °C for 16 hours. The seed culture thus obtained may then be poured into the 1950 milliliters of the same medium containing LDO as a major carbon source. The culture was incubated for 24 hours at 30 °C with shaking. The cells may be harvested as a source of KDO aldolase enzyme. For routine culture preservation, the culture can grow on LB medium and can be incubated overnight at 30 °C. This strain of Aureobacterium barkerei is shown to be a source of KDO aldolase (EC 4.1.2.23) having a broad JBSTITUTE SHEET (RULE 26) εubεtrate εpecificity with respect to the reverse aldol condensation reaction. A new source of KDO aldolase KDO aldolase (EC 4.1.2.23) was first reported by Ghalambor and Heath in 1966 as the enzyme responsible for the KDO degradation (Scheme I) . After their preliminary investigation on the subεtrate specificity as well as the μmol scale syntheεis of KDO, no synthetic application of this enzyme has been reported, while the related enzyme N-acetylneuraminic acid (sialic acid) aldolase has been extenεively studied. It is diεcloεed herein that the Gram-positive bacterium Aureo_bacterium JarJerei strain KDO-37-2 can be induced to contain high levels of KDO aldolaεe. The aldolaεe activity from thiε source waε assayed according to A inoff's method (Biochem . J . 1961, 81 , 384). Two literε of culture contained 10.2 U baεed on the degradation of KDO. Thiε KDO activity is 4 times and 8 times higher than the correεponding KDO activity from Eεcherichia coli K-12 and Aerobacter cloacae , reεpectively, aε reported by Gharambor (supra) . Partially purified KDO aldolase εimply obtained by ammonium εulfate precipitation (8.0 U/mL; 0.19 U/mg for degradation of KDO) was used in subεtrate-εpecificity εtudies reported herein. The KDO aldolase employed for the kinetic analysis reported herein, was further purified via DEAE εepharoεe and phenyl sepharose column chro atography to a specific activity of 5.7 U/mg. The K„, for D-arabinose and V maλ are 1.2 M and 0.73 U/mg, respectively. The unusually high concentration of K___ in the condensation compared with that in the course of degradation (6 x 10 '3 M for KDO) indicates that the enzyme may accept the open form of aldoses as acceptors in the aldol condensation. The enzymatic reaction favors the cleavage of KDO, with the equilibrium constant K cq = [pyruvate] [arabinose]/KDO = 9xl0" 2 M. UB8TiTUTE SHEET (RULE 26) Table L Relative ates of Several Substrates for KDO Aldolase from Aur obact rium barkerei KDO-37-2 substrate relative rate* 3 substrate relative rate- 0 a) Measured at pH 1.5 with 500 πM of sugar and 10 M of pyruvaic. For detailed condition, see experimental. Specific activity based on ι arabinosc is 0.2 U/∑ng; 1 U = 1 μmol KDO formed per min. b) Not detectable. c) Ruoropyruvatε (10 M) was used instead of pyruvate. D-ara nose KD01:X = N}i, + -H 2 0 Scheme II (a) D- bose Scheme II (b) - eoxy-D-ribose Scheme II (c) Scheme II (d) Scheme II (e) D-uireosε 11 11' 12 Scheme II (f) -glyceraldebyde -KDG: 13 13' 14 Scheme II (g) KDO aldolase L-mannose CH3 [α] D +26.3° (CHCI 3 ) Scheme II (h) sialic acid aldolase D-mannose D-KDN: 15' 16 * [α] D -26.0° (CHC1 3 ) 17b 18 19 Scheme II (i) Substrate specificity This enzyme exhibits a wide substrate specificity. S everal 3-6 carbon sugars were accepted as substrateε for the condensation. From the results shown in Table I and Figure 1, the structural requirements of the sugar for this enzyme are as follows. At C-2 position, although the aldolase prefers an S configuration, the difference is not significant [examples: between L- and D-glyceraldehyde; D-threose and D-erythrose; D-arabinose, D-riboεe and 2-deoxy-D-ribose] . It is noteworthy that thiε enzyme alεo accepts D-ribose aε a good εubεtrate (rel. V = 72%) , while that from E . coli or Aerobacter cloacae poorly acceptε thiε εubstrate (rel. V <5%) , according to Gharambor (supra) . At C-3 position, this enzyme prefers an ^-configuration [examples: comparison between D-arabinose and L-arabinose, D-lyxoεe and D-xyloεe] . Hexoseε are generally not aε good εubstrateε as tetroses and pentoεeε, even in the caεe of D-altroεe (rel. V = 25%) and L-fucose (rate not detectable) , both being homoanalogs of the natural subεtrate D-arabinose. The reaεon that L-mannoεe iε a better εubstrate than D-mannoεe is becauεe the former haε the favorable 2R, 3R configurations and the latter haε the unfavorable 2S, 3S configurationε. Finally, neither fluoropyruvate nor ketohexoεe waε accepted by this enzyme. The aldol condensation The enzymatic synthesis of KDO on multi-mmol scales uεing 10 molar excess of pyruvate worked well (e.g. 1 was obtained in 67% yield) . The synthetic route iε illuεtrated in Scheme II (a) . The reagentε employed in this synthesis are as follows: Step Reagent or Enzyme (a) KDO aldolaεe (b) Ac 2 0/py,DMAP (c) CH,N-,. The yield of the enzymatic reaction is comparable to the highest one obtained by the modified Cornforth synthesis (66%) . The crystalline KDO ammonium salt onohydrate waε isolated in 37% yield: [α] 26 D +40.3° (c 2.06, H 2 0) [lit. according to Unger: [α] 2 D +42.3° (c, 1.7, H 2 0) , authentic εample from Sigma [α] 26 D +40.2° (c 2.06, H 2 0) ] . (Unger: Adv. Carbohydr. Chem. Biochem. 1981, 38, 323.) The ] H NMR εpectru in D 2 0 is identical with that of an authentic sample, although it is complicated by the fact that KDO existε aε an anomeric mixture of pyranoεe and furanose forms, and readily cyclizeε to the corresponding lactone in aqueous solution. The crystalline ammonium salt was further converted to pentaacetate methyl ester derivative 2, whoεe *H NMR εpectrum waε in good accordance with that reported previously and clearly shows the 5 C 2 -pyranose conformation (Table II) . Several substrates with good or fair relative rate are shown to be employable in the aldol condensation. The reactions with D-ribose and 2-deoxy-D-ribose are illustrated in Schemes II (b) and (c) respectively. These reactions took place smoothly to give 3 (57% after derivation to 4) and 5 (47% as 6) , respectively. -H NMR εpectra of 3, A , 5, and 6 clearly show a 5 C 2 pyranose form in both productε (Table III) . The -R εpectrum of 6 is shown in Fig. 2. It is noteworthy that in these caseε, even though the relative rates are lower (72% for D-ribose and 71% for 2-deoxy-D-ribose) than that of D-arabinoεe, TLC analyεiε of the reaction productε εhowed no εtarting material left, whereas a substantial amount of εtarting material always remainε in the reaction with D-arabinoεe. It iε suggeεted that formation of the pyranoεe form of 3 and 5, where all εubstituents are located in the stable orientation, further εhifted the equilibrium toward condensation. Table II. -H NMR Analysis of Py^nosε, Fuπ^nose and l—»5 Larionc Foπns Observed in ihc Producis Possessing C-5 Axia. Subsήtucn: in xhc Pyτ * anosc Foπn α-pynnost form: β-pyranosε orm: furanosc form: lactone form: X • = OH or OAc X « OH Y - K-3 and K-3' X - OK or OAc Table IH ] H NMR Analysis of thε α-Pyπinosε Form Observed in the Producis Possessing C-5 Equatoπa] Subsriruεni compound chemical shifis (δ, pp ) coupling consents (Hz) H-3εq K-3ax ^5c -a */3eς Jlsx •* 7 3eς.5eq The products 7 (3-deoxy-D-araJi_no-2-heptulosonic acid, DAH, 39% as 8) and 9 (11% as 10) were also obtained from D-erythroεe and D-glyceraldehyde, as illustrated in Schemes II (d) and (e) respectively. These yields indicate that this aldolase-catalyzed condensation is also useful for the synthesis of lower ho ologs of KDO. The phosphate of 7 (DAHP) plays an important role in the shikimate synthesis pathway in plants and microorganisms. The selected chemical shifts and coupling constants for the Η NMR spectra of products 3-10 are summarized in Table III. Scheme II (f) illustrates the aldolase catalyzed condensation reaction can be employed to produce product 11 from D-threose. Product 11 has a -H NMR spectrum similar to that of KDO. The reaction with L-glyceraldehyde, illustrated in Scheme II (g) afforded 13 (2-keto-3-deoxy-L-gluconic acid, KDG) , an enantiomer of D-KDG, whose phosphate (KDGP) is an intermediate in the Entner-Doudoroff pathway. (Entner, N.; Doudoroff, M. J . Biol . Chem . 1952, 196 , 853.) The "H NMR spectrum of 13 was very complicated (see experimental) . To clarify the stereochemistry, preparation of derivatives was attempted; however, the productε were still difficult to identify. The only isolable component from 11 was a bicyclic lactone. The structure was determined as 12 (Scheme II) by comparing its Η NMR spectrum with that of the higher homolog 12' , which had been obtained from KDO and unambiguously characterized previously. (Charon, D. ; Auzanneau, F.-I.; Merienne, C; Szabό, L. Tetrahedron Lett . 1987, 23 , 1393.) In its ! H NMR spectrum (Table II) , a long range coupling between H-3 and H-5 (0.6 Hz) indicates that the pyranose form of the product exists as a twisted boat conformation, and all of the coupling constants are consistent with those observed in the case of 12'. It is interesting that in the spectra of 11, 13 and KDO, a substantial proportion of the similar signals were observed, where one of the H-3 signal appears at very low field (Table II) . From these results, it is assumed that the bicyclic 1«5 lactones l', 11' and 13' form at nearly neutral pH. The formation of 1«7 lactone is excluded, since those signals were observed in the case of a hexulosonate 13' without any C-7 hydroxy group. The homologε prepared here also proceed through a spontaneouε 1«5 lactone formation, as already proposed previously for KDO. (Menton, L.D., et al. Carbohydr . Res . 1980, 80 , 295.) Compound 13 mainly exists as 5 C 2 pyranose form as indicated in 14. The reaction with L-mannoεe illustrated in Scheme I I ( h ) g a v e l 5 (3-deoxy-L-grlycero-L-g-alacto-2-nonulosonicacid, L-KDN, 61% as 16) , which iε an enantiomer of D-KDN, a component in polysialoglycoprotein and ganglioside of rainbow trout eggs. (Lin, C.-H., et al., J . Am . Chem . Soc , in preεε; Nadano, D. et al. J. Biol . Chem . 1986, 261 , 11550; and Song, Y. , et al. J . Biol . Chem . 1991, 266 " , 21929.) The optical rotation [[α] 2 ^ +26.3° (CHC1 3 ) ] and ! H NMR εpectrum of 16 were in good accordance with thoεe of 16' [[α] 25 D -26.0° (CHC1 3 ) ] , which waε obtained via reaction with D-mannose catalyzed by sialic acid aldolase, as illustrated in Scheme II (i) , except for the sign of rotation (Tetrahedron 1990, 46 , 201). The availability of both enantiomers of KDN may develop new analogs of εialyl oligosaccharides. (Ichikawa, Y., et al. Anal . Biochem . 1992, 202 , 215.) Finally, the aldol reaction with an unnatural εugar containing a fluorine atom was conducted to give 18 (19% of 19) . By comparing the Η NMR εpectra, the proportion of the / 3-iεomer (10.71) of 18 waε ca . 1.5 times higher than that of KDO (6.9%), probably due to the absence of furanose and 1«5 lactone forms. This result suggests that 18 might be a good εubstrate for CMP-KDO εynthetase, since the enzyme accepts the unstable 9-form of KDO as a substrate. (Kohlbrenner, .E. and Feεik, S. ., J. Biol . Chem . 1985, 260 , 14695.) We therefore synthesized 18 in a larger scale by combining the use of KDO aldolase and pyruvate decarboxylase, which made the workup procedure much easier. Preliminary study using 18 toward CMP-KDO εynthetaεe which had recently been cloned and over- expreεεed in thiε group showed that 18 was accepted to the enzyme. Based on these reεultε, the εtereochemical courεe of the aldol condenεation catalyzed by thiε KDO aldolaεe iε probably aε followε: The attack of pyruvate alwayε takeε place on the re face of the carbonyl group of the εubεtrateε, a facial selection complementary to sialic acid aldolaεe reactionε (εi face attack) . The εtereochemical requirements of substrates and the stereoche ical course of the aldol condensation are indicated in Fig. 3. It is concluded that in general the enzyme accepts substrateε with an _R-configuration at C-3. The εubεtrateε with an S configuration at C-2 iε kinetically favored, while those with R configuration at C-2 are thermodynamically favored to give a better yield. Synthesis of decarboxylated analogs Decarboxylation of KDO and its analogε will yield the correεponding aldoεe derivativeε. A εynthetic route employing decarboxylation of KDO aldolaεe condensation productε is illustrated in Schemes III (a) and (b) . The reagents employed in theεe εynthetic routes is as follows: Step Reagent (a) Ac 2 , DMAP/pyridine (b) CsC0 3 , BnBr/DMF (c) H 2 , Pd-C/EtOH (d) ( COCl ) 2 /toluene (e) 17 , DMAP/pyridine-toluene (f ) t-BuSH , hv (g) Me 3 N=C=NEt (WSCI)-Cl, .17 (5 eq.), T-CuSH, DMAP, Et 3 N, MS4A/Ch 2 Cl 2 , hv The aldodeoxyheptoεe εtructure iε particularly intereεting εince a number of heptoseε are widely diεtributed in nature, some of which play important roleε in metabolic pathwayε. Barton's radical-mediated decarboxylation of the penta-O-acetyl derivative 20a obtained from the correεponding benzyl ester 2Ob seemε to be the moεt εtraightforward route to the deεired heptoεe derivative 21. (e.g., Crich, D. and Lim, L.B.L. J . Chem . Soc . Perkin I 1991, 2209 and Auzanneau, F.-I. et al. Carbohydr . Res . 1990, 201 , 337.) There have recently been growing intereεts in the syntheεis of physiologically active carbohydrate- and nucleic acid-related compounds via anomeric radical intermediates. It appears to us that radical-mediated reaction stabilized both electron withdrawing and donating group (capto-dative effect) , e.g. Viehe, H.G. et al. Ace . Chem . Res . 1985, 18 , 148.)at anomeric position [-C(») (OAc)O-type] is rare (only a few related examples [eg. -C(-») (C0 2 Me)0- type, -C(«) (CHF 2 )0- type] are known) , while examples in the case of simple Tetraconal structure Scheme III (a) 23a 22 24 Scheme III (b) anomeric radical [-C(») (H or R)0- type] and the one bearing two electron donating oxygen atom [-C(»)(OR))- type] have been extenεively εtudied. (e.g. Crich, D. and Lim, L.B.L. J . Chem . Soc . Perkin I 1991, 2205 and J . Chem . Soc . Perkin I 1991, 2209 ,' .Schmidt, R. et al. Tetrahedron Lett . 1988, 29 , 3643; Myrvold, S. et al. J. Am. Chem . Soc . 1989, 211, 1861; Motherwell, W.B. et al. Synlett . 1989, 68 ; and Samadi, M. J. Med . Chem . 1992, 35 , 63.) The radical intermediate waε formed by the thermal decompoεition of the thiohydroxamate 20c generated in situ from the correεponding acid chloride and 22 in the presence of azobisisobutyronitrile (AIBN) . The subsequent trapping with tributyltin hydride resulted in only a disappointing (lesε than 2%) yield of 21. The yield was, however, dramatically improved to 68% by irradiation with white light in the presence of t-butylmercaptane. The ] H NMR spectrum of 21 clearly εhowε the excluεive -anomer ( δ 5.75, dd, J eq =3.0, I>2ΛX =10.0 HZ, H-l) , indicating that the abεtraction of hydrogen atom from t-butylmercaptane took place at the bottom εide of the εix-membered ring. The proposed mechaniεm for the excluεive formation of -iεomer iε aε followε. The εtable conformer of the radical intermediate which is stabilized both by the electron-donating and withdrawing effects is εuppoεed to be in a plane form aε depicted in Scheme III, which allowε the maximum interaction between the one-electron p orbital and the lone pair electronε on the adjacent ring oxygen. t-Butylmercaptane iε eaεily acceεεible from the bottom εide, while the approach from the top εide iε sterically hindered by the hydrogen and acetoxy groups. This explanation in terms of kinetic control is well matched with the thermodynamic stability of the / 3-product. SUBSTITUTE SHEET (RULE 26} The radical process was also applied to the synthesis of the decarboxylated analog of W-acetylneuraminic acid. It turned out, however, that all attempts for the synthesis of the acyl chloride resulted in a complex mixture, even from fully protected peracetate form 23a of sialic acid, because NHAc proton still haε a εubεtantial reactivity to chlorinating reagentε. The direct formation of thiohydroxamate 23b waε alεo found to be difficult becauεe of the inherent steric hindrance around carbonyl group in the εtarting material. Through an extenεive examination of the reaction conditionε, it waε found that the combination of ethyl (diethylamino)propylcarbodiimide hydrochloride (WSCI-C1, 1.5 eq) and exceεε of 22 (5.0 eq) worked well for the in situ formation and degradation of thiohydroxamate, to give 24 (27% yield from 23a) . Thiε condition haε the advantage that the reaction can be carried out in one εtep. The newly formed product waε excluεively an α-anomer where the OAc group iε located in the equatorial orientation, consistent with the result obtained in the decarboxylation of KDO derivative. (Haverkamp, J. et al. Eur . J . Biochem . 1982, 122 , 305.) Preparation of Examples General Optical rotationε were measured on Perkin-Elmer 241 spectrophoto eter UV and viεible εpectra were recorded on a Beck ann DU-70 εpectrometer. Η and 13 C NMR εpectra were recorded at 400 and 500 MHz on Bruker AMX-400 and AMX-500 εpectrometer. High-resolution masε spectra (HRMS) were recorded on a VG ZAB-ZSE mass spectrometer under fast atom bombardment (FAB) conditions. Column chromatography was carried out with silica gel of 70-230 mesh. Preparative TLC was carried out on Merck Art. 5744 (0.5 mm). Isolation of the microorganism Aureobacterium barkerei containing high levels of KDO aldolaεeε was selected with the S medium containing 0.25% of εynthetic KDO mixture aε carbon εource (20 L) in εerum bottleε (158 mL) and incubated at 37°C for 2 dayε with εhaking (250 r.p.m.). (McNicholaε, P.A. et al. Carbohydr . Res . 1986, 146 , 219 and Shirai, R. ; and Ogura, H. Tetrahedron Lett . 1989, 30 , 2263.) The bottleε which εhowed turbidity were tranεferred to the εame freεh medium. After several transfers, the cultures were plated on the S medium agar plates (1.5 % agar) containing 0.25% of εynthetic KDO mixture. The iεolated colonieε were tranεferred to the liquid medium aε deεcribed above. To confirm the utilization of KDO, the disappearance in the medium waε monitored by TLC aε deεcribed in the synthesis of KDO. The cultures which showed the utilization of KDO were harvested by centrifugation and resuεpended in 50 mM phosphate buffer (pH 7.0). The cell suspenεion waε incubated with 1% (w/v) of authentic KDO (from Sigma) at 37°C overnight to confirm the degradation of KDO by TLC. The cultureε were then replated on LB agar plateε to enεure the purity of the culture. Preparation of the enzyme With one slight modification, the incubation was carried out according to the procedure reported by Ghara bor (supra) . The ingredients of the medium were aε followε: NH 4 C1 (5 g) , K,S0 (1 g) , MgS0 4 -7H 2 0 (200 mg) , CaCl 2 (20 mg) , FeS0 4 *7H,0 (1 mg) , yeast extract (1 g) , Na 2 HP0 4 -7H 2 0 (10 g) , and KH 2 P0 4 (3 g) in distilled water (1 L) , at pH 7.2. To a 50 mL of thiε medium in a 100 mL Erlen eyer flask, were added D-glucose (40% solution in water, 25 μL) and KDO (100 mg, 0.2%), and a loopful of Aureobacterium barkerei KDO-37-2 was incolutated. The flask was shaken at 250 r.p.m. on a gyrorotary εhaker at 30°C for 16 h. The εeed culture thus obtained waε poured into the 1950 mL of the same incubation medium containing KDO (3.9 g) . The mixture waε divided and poured into two of 2.8 L Erlenmeyer flasks. The flasks were shaken at 250 r.p.m. at 30°C for 24 h. The growth of microorganism waε eεtimated by OD at 600 nm to be 1.90. The cellε were harvested at 10,000 x g for 30 in at 4°C and waεhed with 50 mM potaεεium-εodium phoεphate buffer (pH 7.5). The collected cellε were then reεuεpended in the εame buffer εolution (20 mL) and diεrupted by French-preεεure apparatuε (at 16,000 lb/in). The cell debriε were removed by centrifuge at 23',000 x g for 1 h at 4°C to give the εupernatant ( ca . 20 L) aε the crude enzyme preparation. The enzyme activity was determined to be 1.45 U/mL for the degradation of KDO according to the method of Aminoff (Biochem . J. 1961, 81 , 384) . Ammonium sulfate precipitation between 45-75% εaturation was collected and dialyzed in phosphate buffer (2 L; 100 mM, 1 mM of dithiothreitol, 2 L) to give partially purified enzyme (13.5 L, 1.73 U/mL for KDO degradation) , according to the method of Kim (J . Am . Chem . Soc . 1988, 110 , 6481) . Kinetic measurements The rates for aldolase-catalyzed reactionε were obtained by meaεuring the amount of remaining pyruvate, according the method of Kim (εupra) . The reactions were carried out in 0.1 M phosphate buffer (pH 7.5) containing: varied concentrations of pyruvate, 2.0, 3.33, 5, and 10 M; varied concentrationε of D-arabinose, 0.2, 0.25, 0.33, and 0.50 M in 0.5 L of solution. Each solution was incubated at 37°C. Periodically, a small aliquot (25-100 μL) was withdrawn and mixed with an assay εolution (1.4 mL) containing 0.1 M phosphate (pH 7.5) buffer, 0.3 mM NADH, and 20-30 U of L-lactate dehydrogenase. The decrease in absorbance at 340 nm was measured and converted into the amount of the unreacted pyruvate using 6220 M " 'cm * - for the molecular absorbance of NADH. The kinetic parameters were obtained from the Lineweaver-Burk plots. For the relative rate measurements, the concentration of pyruvate (fluoropyruvate) and sugar were fixed at 10 mM and 0.5 M, respectively. Other conditionε were the same as above. Example 1 Ammonium 3-deoxy-α-D-ma_n_no-2-octulosonate monohydrate (KDO ammonium salt monohydrate, 3L) . D-Arabinose (250 mg, 1.67 mmol) , έodium pyruvate (1.83 g, 16.7 mmol), dithiothreitol (1.5 mg) , NaN 3 (2% εolution in water, 100 μL) , NaHP0 4 -7H 2 0 (53 mg) , and KH 2 P0 4 (13 mg) were added to the KDO aldolase (5.1 U, 10 mL) . The pH waε adjuεted to 7.5 and the mixture waε εtirred under N 2 at 30°C for 3 dayε. The product waε purified by treatment with a Dowex-1 reεin column (bicarbonate form) eluted with a linear gradient from 0 to 0.25 M of ammonium bicarbonate. KDO ammonium εalt waε further purified by Biogel P-2 column. The fraction eluted with H 2 0 containing KDO was collected and its total amount was estimated to be l.ll mmol (67%) by A inoff's aεεay (εupra) . The residue after lyophilization waε recryεtallized from aqueouε ethanol to give colorleεε plateε (168 mg, 37% from D-arabinoεe) : p 123-125°C (decompoεition) [lit. according to Hershberger: mp 121-123°C, authentic εa ple from Sigma mp 123-125°C (decompoεition)]; [α] 26 D +40.3° (c 2.06, water) [lit. according to Hershberger: [α] 27 D +42.3° (c 1.7, water), authentic sample from Sigma [ ] 26 D +40.2° (c 2.03, water)]. Itε Η NMR εpectrum in D 2 0 was identical with that of an authentic sample. (Hershberger: J. Biol . Chem . 1968, 243 , 1585.) . A small portion was converted to pentaacetate methyl eεter derivative 2: Η NMR (CDC1 3 ) δ 1.994 (3H, ε, acetyl) , 1.998 (3H, ε, acetyl) , 2.045 (3H, ε acetyl) , 2.108 (3H, ε, acetyl) , 2.139 (3H, ε, acetyl) , 2.201 (1H, dd, J 3ax . 4 =12.0, J 3ax-3e< =13.0 Hz, H-3ax) , 2.245 (1H, dd, J 3eq4 =6.0, J 3eq . 3ax -=13.0 Hz, H-3eq) , 3.810 (3H, ε, COOCH 3 ) , 4.113 (1H, dd, J r<7 =12.5, J g . ιg =12.5 Hz, H-8' ) , 4.173 (1H, dd, J 65 =1.3, J 67 =9.5 Hz, H-6) , 4.475 (1H, dd, J g7 =4.0, J .=12.5 Hz, H-8) , 5.220 (1H, ddd, J 7g =4.0, J 76 =9.5, J 78 .=12.5 Hz, H-7) , 5.322 (1H, ddd, J 45 =3.0, J 4 . 3« .=6-0, J 4 . 3eς =6.0, J 4 . 3ax =12.0 HZ, H-4), 5.385 (1H, dd, J J6 =1.3 , J 54 =3.0 Hz, H-5) . The -H NMR εpectrum waε in good accordance with that reported previouεly by Unger (Adv. Carbohydr. Chem. Biochem. 1981, 38, 323). Example 2 Methyl 2,4,5,7,8- enta-0- ce yl-3-deo y- c.-D-a.2t.ro-2-oc uloson te (4.) . In the εame manner as described for the preparation of 1, the product 3 (as ammonium salt) was prepared from D-riboεe (0.33 mmol): -H NMR (D 2 0) δ 1.773 (1H, dd, J 3ax . 4 =11.9, J 3ax . 3« ,-=13.0 Hz, H-3ax) , 2.148 (1H, dd, J 3eqι4 =5.1, J 3eq . 3aλ =13.0 HZ, H-3eq), 3.500 (1H, dd, J 5 . 4 =9.1, J 56 =10.0 Hz, H-5) , 3.745 (1H, dd, J 87 =7.3, J 8 . 8 .-=12.1 Hz, H-8), 3.789 (1H, dd, JV. 7 =3.7, J u =12.1 Hz, H-8') , 3.809 (1H, dd, J 6-7 =2.8, J 65 =10.0 Hz, H-6) , 3.901 (1H, ddd, J . 3c r 5 - 1 J Λα ll.9 Ha, H-4) , 4.004 (1H, dd, J 7-6 =2.8, " 7g .=3.7, J 7S =7.3 Hz, H-7). Thiε waε converted to 4 by the εucceεεive treatment with acetic anhydride-pyridine-DMAP (εee alεo the preparation of 20b) and etherial diazomethane εolution. The product was purified with silica gel preparative TLC to afford 4 (87.7 mg, 57% from D-ribose) as an oil, [α] 25 D +70.9° (C 0.81, CHC1 3 ) ; Η NMR (CDC1 3 ) δ 2.010 (1H, dd, J 3ax4 =11.6, J 3ax3cq =13.5 Hz, H-3ax) , 2.030 (3H, s, acetyl) , 2.050 (3H, s, acetyl) , 2.064 (3H, ε, acetyl) , 2.105 (3H, s, acetyl) , 2.154 (3H, ε, acetyl) , 2.559 (1H, dd, SUEtSTITUTE SHEET (RULE 26) J 3eq . 4 -=5.2 , J 3eq . 3ax =13.5 Hz, H-3eq) , 3.793 (3H, ε, C00CH 3 ) , 4.084 (IH, dd, J 6,7 =3.2, J 65 =10.3 Hz, H-6) , 4.241 (IH, dd, J g7 =7.0, J w .=12.0 HZ, H-8) , 4.415 (IH, dd, J g . ,7 =4.0 J,. fg =12.0 HZ, H-8') , 5.110 (IH, dd, J 5,4 =9.3 , J 5-6 =10.3 Hz , H-5) , 5.169 (IH, ddd, J 76 =3.2, J 7g .=4.0, J 7g =7.0 Hz , H-7) , 5.271 (IH, ddd, J eq =5.2, J 4-J =9.3 , J 4 . 3ax =ll.6 Hz, H-4 ) ; ,3 C NMR (CDCl j ) δ 20.52, 20.56, 20.56, 20.67, 20.67, 35.47, 53.12, 61.23, 68.33, 68.96, 69.85, 71.98, 96.66, 166.21, 167.94, 169.52, 169.85, 169.89, 170.38. HRMS (M+Cε + ) calcd C 19 H 26 0 13 Cε 595.0428, found 595.0428. Example 3 Methyl 2,4,7, 8-tetra-0-acetyl-3 , 5-dideoxy- α-D-_raa_n_no-2-octulosonate (6 . ) . In the same manner aε 3, the product 5 (as ammonium εalt) waε prepared from 2-deoxy-D-riboεe (0.33 mmol): Η NMR (D 2 0) δ 1.400 (IH, ddd, J iMxA =ll.9, J 5ax,6 =11.9, J 5ax . 5eq =12.3 HZ, H-5ax) , 1.591 (IH, dd, Hz, H-3ax) , 2.009 (IH, dddd, 2.094 (IH, ddd, J 3eq . 5cς =l • 8 , J 3tq . 4 =4.6 , J 3eq . 3ax =12.7 Hz, H-3eq) , 3.398 (IH, dd , J g7 =7.1 , J 8S .=11.8 Hz, H-8) , 3.588 (IH, dd, J r7 =4.1, J s . g =11.8 Hz, H-8') , 3.786 ( IH , ddd, J 7 . g .=4.1, J 76 =4.6, J 7g =7.1 H8, H-7) , 3.945 (IH, ddd, J 6 . 5cq =2.2, J 6 . 7 =4.6, J 65ax =11.9 HZ, H-6) , 4.112 (IH, dddd, J 4 . 3e , β 4.6 , J 4 . 5eq =4.6 , J 4-Sax =11.9, J 4 . 3ax =12.1 Hz , H-4) . Thiε waε converted to 6 (62.2 g, , 47% from 2-deoxy-D-riboεe) : [α] 25 D +86.0° (c 0.56, CHC1 3 ) ; ] H NMR (CDC1 3 ) S 1.488 (IH, ddd, J 5ax . 4 =12.0, J 5ax . 6 =12.0 , J 5ax-5cς =12.7 Hz, H-5ax) , 1.783 (IH, dd, J 3ax4 = 11.6 , J 3ax . 3cq =13.1 Hz, H-3ax) , 2.045 (3H, ε, acetyl) , 2.054 (3H, s, acetyl) , 2.070 (3H, s, acetyl) , 2.123 (3H, s, acetyl) , 2.177 (IH, dddd, J 5cq _ 3cq =l.8, J 5cq . 6 =2.2 , J 5eq4 =4.7, J 5eqJax =12.7 Hz, H-5eq) , 2.454 (IH, ddd, J 3cq . Jcq =l .8 , J 3cq . 4 =4.8 , J 3cq . 3ax =13.1 Hz, H-3eq) , 3.782 (3H, s, COOCH 3 ) ■ 4.034 (IH, ddd, J 65cq =2.2, J 6-7 =7.6, J 65ax =12.0 Hz, H-6) , 4.169 (IH, dd, J g7 =5.1, J M .=12.2 HZ, H-8) , 4.457 (IH, dd, J g . 7 =2.8 , J g . -g =12.2 Hz, H-8') , 5.093 (IH, ddd, J 7-g .=2.8 , J 7tg -5.1, J 76 =7.6 HZ, H-7) , 5.186 (IH, dddd, J 4 . Seq =4.7 , J 4>3eq =4.8 , J 4 . 3ax =11.6, J 4 . 5« =12.0 Hz, H-4) ; ,3 C NMR (CDC1 3 ) δ 20.56, 20.56, 20.73, 20.96, 32.21, 36.03, 52.96, 61.82, 65.72, 69.00, 71.96, 97.61, 167.02, 167.96, 169.81, 170.06, 170.32. HRMS (M+Cs + ) calcd C π H 24 O π Cε 537.0373, found 537.0373. Example 4 Methyl 2,4,5,7-tetra-0-acetyl-3-deoxy- α-D-araJ ino-2-heptulosonate (8.) . 7: Η NMR (D 2 0) δ 1.773 (IH, dd, J 3tx-4 =11.8 , J 3ax . 3« ,= 13.0 Hz, H-3ax) , 2.180 (IH, dd, J 3eq4 =5.1, J 3eς,3ax =13.0 Hz, H-3eq) , 3.433 (IH, dd, J 5,4 =9.2 , J 5 . 6 =9.5 Hz, H-5) , 3.744 (IH, ddd, J 67 =3.5, J 6-7 .=3.5, _J 65 =9.5 Hz, H-6) 3.807 (IH, m, H-7) , 3.812 (IH, , H-7 ' ) , 3.930 (IH, ddd, 8: (50.0 mg, 39% from 0.33 mmol of D-erythroεe) : [a]-"D +54.0° (c 0.50, CHC1 3 ) ; ~ E NMR (CDC1 3 ) δ 2.034 (3H, ε, acetyl) , 2.053 (3H, ε, acetyl) , 2.087 (3H, ε, acetyl) , 2.087 (IH, dd, J 3ax . 4 =11.4, J 3ax-3c =13.6 Hz , H-3ax) , 2.173 (3H, ε, acetyl) , 2.658 (IH, dd, J 3eq4 =5.2, J 3cq . 3« _=13 • 6 Hz, H-3eq) , 3.808 (3H, ε, COOCH 3 ) , 4.058 (IH, dd, J 67 =2.3, J 67 .=4.3, J 6J =10.2 Hz, H-6) , 4.100 (IH, J 76 =2.3, J 77 .=12.4 HZ, H-7) , 4.355 (IH, J r . 6 =4.3 , J r>7 =12.4 HZ, H-7') ; 13 C NMR (CDC1 3 ) δ 20.65, 20.76, 20.76, 20.84, 35.58, 53.31, 61.69, 68.16, . 68.37, 71.51, 97.29, 166.41, 168.43, 169.61, 170.13, 170.77. HRMS (M+Cε + ) calcd C 16 H 22 O π Cs 523.0216, found 523.0216. Example 5 Methyl 2,4, 5-tri-0-acetyl-2-keto-3-deoxy-α-D-galactonate (.10.) . 9: -H NMR (D 2 0) δ 1.795 (IH, dd , J 3ax4 =ll.6 , J 3l [(1 =13.1 Hz, H-3ax) , 2.176 (IH, dd, J 3eq . 4 =5.1 , J 3cq3ax =13.1 Hz, H-3eq) , 3.60-3.65 (2H, m) , 3.77-3.91 (2H, m) . 10: (11.0 g, 11% from 0.33 mmol of D-glyceraldehyde) : [α] 2S D +31.8° (c 1.10, CHC1 3 ) ; Η NMR . (CDC1 3 ) δ 1.948 (IH, dd, J 3ax . 4 =11.2, J 3ax,3c =13.5 Hz , H-3ax) , 2.055 (3H, ε, acetyl) , 2.059 (3H, ε, acetyl) , 5 2.170 (3H, ε, acetyl) , 2.618 (IH, dd, J 3cq,4 =5.2 , J 3« ,. 3« =1 .5 HZ, H-3eq) , 3.629 (IH, dd, J^^IO .6, J 6ax-6eq =11.3 Hz, H-6ax) , 3.809 (3H, ε, COOCH 3 ) , 4.149 (IH, dd, ^. 5 =5.7, ^. 6 ^11.3 Hz, H-6eq) , 5.049 (IH, ddd, J 5 . 6« ,=5 • 7 , J 5 . 4 =9-5, J 5 . 6ax =10.6 HZ, H-5) , 5.320 (IH, ddd, ° J cq =5.2, J 4-J =9.5, J 4 . 3ax =11.2 Hz , H-4) ; 13 C NMR (CDC1 3 ) δ 20.67, 20.72, 20.89, 35.81, 53.25, 62.17, 67.66, 68.49, 96.80, 166.96, 168.50, 169.84, 170.05. HRMS (M+Cε + ) calcd C 13 Hι 8 0 9 Cε 451.0005, found 451.0005. Example 6 5 2,4,7-Tri-0-acetyl-3-deoxy- α-D-2yxO-2-heptulosonic acid 1«5 lactone (.12.) . 11: 'H NMR (D 2 0) δ 1.90-1.98 (m, H-3 of the major component) ; a minor pair of H-3 protonε: 2.072 (dd, 0 Hz, H-3') ; another minor pair of H-3 protonε: 2.301 (dd, -=7.0, 13.4 Hz) , 2.384 (dd, J=7.0, 13.4 Hz) ; 3.60-3.95 (m) , 3.95-4.20 (m) , 4.48-4.52 (m) . 12: (1.9 mg) : Η NMR (CDC1 3 ) δ 2.096 (3H, ε, acetyl) , 2.127 (3H, ε, acetyl) , 2.180 (3H, ε, acetyl) , 5 2.339 (IH, ddd, J 3 . 5 =0.6, J 34 =2.4 , J 33 .=14.9 Hz, H-3) , 2.972 (IH, dd, J 3 . 4 =9.4, J 3 . 3 =14.9 Hz, H-3 ' ) , 4.180 (IH, ABX type, J 67 =5.6, J 67 .=9.9 Hz, H-6) , 4.28-4.35 (2H, m, ABX type, H-7 , H-7 ' ) , 4.904 (IH, d, J J4 =2.0 Hz, H-5) , 5.164 (IH, ddd, J 45 =2.0 , J 43 =2.4 , J 4 . 3 -=9.4 Hz, H-4) . HRMS 0 (M+Cε + ) calcd C 13 H, 6 0 9 Cs 448.9849, found 448.9858. Example 7 Methyl 2 , , 5-tri-0-acetyl-2-keto-3-deoxy- α-L-gluconate (.14 . ) . 13 (L-KDG) : Η NMR (D 2 0) A major pair of H-3 protonε: δ 1.873 (dd, J 3cq . 4 =5.2, J 3f< ,. 3ax =13.0 Hz, H-3eq) , 1.984 (dd, J 3ax4 =11.9, J 3ax . 3cq =l3.0 Hz, H-3ax) ; a minor pair of H-3 protonε: 2.051 (dd, J 34 = 3.2, J 3 . 3 .=i4.1 Hz, H-3), 2.521 (dd, J 3 . 4 =7.5, J 3 .. 3 =14. l Hz, H-3 ' ) ; a minor H-3 proton ( 2 C 5 ,9-pyranoεe form iε suggested) : 2.167 (dd, J 34 =4.0, J 33 .=13.7 Hz) , in this case the H-3 ' proton could not be specified by overlapping of the εignalε; another minor pair of H-3 protons: 2.284 (dd, J=6.4, 13.1 Hz), 2.341 (dd, J=6.4, 13.1 Hz) ; 3.60-4.10 (m) , 4.15-4.20 (m) , 4.30-4.40 (m) . 14: (2.0 mg) : Η NMR (CDC1 3 ) δ 2.034 (3H, s, acetyl) , 2.150 (3H, ε, acetyl), 2.152 (3H, ε, acetyl), 2.288 (IH, d, J 3ax4 =10.1 Hz, H-3ax) , 2.292 (IH, dd, ^. 5 =0.4 Hz, J 3eq4 =7.0 Hz, H-3eq) , 3.830 (3H, ε, COOCH 3 ) , 3.999 (IH, dd, J 6eq . 5 =1.5, J 6eq . 6ax =13.2 Hz, H-6eq) , 4.092 (IH, dd, J 6ax . 5 =2.0, J 6ax . 6cq =13.2 HZ, H-6ax) , 5.251 (IH, dddd , J 5 . 3eq =0.4 , J j . 6cq =l .5 , J 5 . 6ax =2.0 , J 54 =2.7 Hz , H-5 ) , 5.313 (IH, ddd, J 4J =2.7 , J 43eq =7.0 , J 4 . 3ax =10.1 Hz, H-4) . HRMS (M+Na + ) calcd 341.0849, found 341.0849. Example 8 Methyl 2,4,5,7,8, 9-hexa-0-acetyl-3-deoxy- ^-L-g yc-sr -L-galacto-nonulo senate (.16.) . 15 (L-KDN) : Η NMR (D 2 0) δ 1.773 (IH, dd, J 3ιx-4 =11.8 , J 3ax . 3« rl2.9 Hz, H-3ax) , 2.168 (IH, dd, J 3cq4 =5.1, J 3eq . 3ax =ll.8 HZ, H-3eq) , 3.579 (IH, dd, J 54 =9.3, J S6 =9.9 Hz, H-5) , 3.654 (IH, dd, J 9g =6.3, J 99 .= 11.8 Hz, H-9) , 3.766 (IH, ddd, J g9 .=2.6, J g9 =6.3, J g7 =9.0 Hz, H-8) , 3.831 (IH, dd, J 76 =l.l, J 7g =9.0 Hz, H-7) , 3.873 (IH, dd, J 9 .. g =2.6 , J 9 .. 9 =11.8 Hz, H-9') , 3.925 (IH, dd, J 67 =l.l, J 6 . 5 =9.9 Hz, H-6) , 3.971 (IH, ddd, J 43t . q =5. ' 1 , J 4 ,=9.3 , J 4 . 3ax =11.8 Hz, H-4) . 16 (108.3 g, 61% from 0.33 mmol of L-mannoεe) : [α] 25 D +26.3° (c 1.14, CHCl 3 ) ; Η NMR (CDCl 3 ) <5 2.084 (IH, Di SSTITUTE SHEET (RULE 26) dd, J 3ax4 =11.6, J 3ax . 3eq =13.6 Hz, H-3ax) , 2.013 (3H, ε, acetyl) , 2.024 (3H, ε, acetyl), 2.040 (3H, ε, acetyl) , 2.069 (3H, ε, acetyl), 2.115 (3H, ε, acetyl), 2.157 (3H, ε, acetyl), 2.625 (IH, dd, J 3eq4 =5.3, J 3eq . 3 . x =13.6 Hz, H-3eq) , 3.790 (3H, ε, COOCH 3 ) , 4.141 (IH, dd, J 9g =5.8, J 99 .=12.6 Hz, H-9) , 4.186 (IH, dd, J 67 =2.3 , J 6 . 5 =10.3 Hz, H-6) , 4.440 (IH, dd, J 9 .. g =2.5, J 9 .. 9 =12.6 Hz, H-9 ' ) , 4.975 (IH, dd, J 54 =9.6, J 56 =10.3 Hz, H-5) , 5.150 (IH, ddd, J g9 .=2.5, J g9 =5.8, J g7 =6.3 Hz, H-8), 5.264 (IH, ddd, J 43eq =5.3, J 45 =9.6, J 4 . 3aλ =11.6 Hz, H-4) , 5.396 (IH, dd, J 76 =2.3, J 7 .r=6.3 Hz, H-7); I3 C NMR (CDC1 3 ) δ 20.46, 20.48, 20.58, 20.58, 20.67, 35.32, 53.06, 61.67, 66.68, 67.21, 68.57, 70.00, 71.27, 97.14, 165.91, 168.03, 169.46, 169.57, 169.80, 169.96, 170.41. HRMS (M+Cs + ) calcd. C 22 H 30 OuCs 667.0639, found 667.0639. 16': [α] 25 D -26.0° (c 1.00, CHC1 3 ) . The ! H NMR spectrum waε identical with that of 16. Example 9 2-Deoxy-2-fluoro-D-arabinose (17b) . To a solution of a tribenzoate 17a (available from Pfanstiehl Co., 500 mg, 1.08 mmol) in ethanol (5 mL) waε added 10 N NaOH aqueouε εolution (485 μL, 1.5 eq of each OBz group, total 4.5 eq) at room temperature. After 15 min, H 2 0 (10 L) and ethanol (5 mL) were added and the mixture waε εtirred and heated to 50°C to diεεolve the precipitated εodiu benzoate. The mixture waε further εtirred for 1 h at room temperature. After ethanol was evaporated in vacuo, the reεidue waε diεεolved in H0 and Dowex 50 -X8 (H + form) waε added to acidify the mixture. The precipitated benzoic acid waε filtered off, and the filtrate waε treated with Dowex 1-XS (HC0 3 ' form) and filtered, then concentrated in vacuo to give 17b aε colorless syrup (153 mg, 94%) ; Η NMR (D,0) δ 3.60-4.20 (4H, m) , 4.337 (ddd, J 2 ,=7.7 , J 2 . 3 =9.3, J 2F =51.δ Hz, H-2 of 3-anomer) , 4.666 (ddd, J 2I =3.7, J 2 . 3 -=9.5, J 2F =49.5 Hz , H-2 of α-anomer) , 4.763 (dd, J, ιF =3.3, J ι. 2 =7. , H-l of -anomer) , 5.434 (dd, J 1F =1.5, J 12 =3.7 Hz, H-l of Q-anomer) . Thiε anomeric mixture waε uεed in the next εtep without further purification. Example 10 Methyl 2,4,7 , β-tetra-O-acetyl-3 , 5-dideoxy-5-f luoro- α-D-jπaιiJ.o-2-octulosonate (JL9.) . 18: Η NMR (D 2 0) δ 1.814 (dd, J 3ax . 3eq -=12.4 , J 3ax4 =12.4 Hz, H-3ax of -anomer) , 1.988 (IH, ddd, J 3eq-5 =0.8 , J 3eq4 =5.6, J 3cq3ax =12.9 Hz, H-3eq of α-anomer) , 2.058 (IH, dd, J 3ax4 =11.8, J 3ax3cq =12.9 Hz, H-3ax of α-anomer) , 2.461 (ddd, J 3q . 5 =0.8, J 3eq . 4 =5.3, J 3eq . 3aλ =12.4 HZ, H-3eq of ^-anomer) , 3.663 (IH, dd, J g7 =5.4, J gg .=12.1 Hz, H-8) , 3.828 (IH, dd, J g .. 7 =2.4 , J g .. g =12.1 Hz , H-8 ' ) , 3.80-3.95 (2H, m) , 4.182 (IH, dddd, J 4 . 5 =2.4 , J 4 . 3cq =5.6 , J 4-3ax =ll.8 , J 4 . F =30.5 Hz, H-4) , 4.957 (IH, ddd, J 53eq =0.8, J i4 =2.4 , J JF =50.9 HZ, H-5) . 19 (25.3 mg, 18% from 0.33 mmol of 17b): [αJ-^D +96.4° (c 2.53, CHCl 3 ) ; Η NMR (CDC1 3 ) δ 2.043 (3H, ε, acetyl) , 2.067 (3H, s, acetyl) , 2.131 (3H, s, acetyl) , 2.137 (3H, s, acetyl) , 2.271 (IH, dd, J 3ax4 =ll.5 , J 3 . χ . 3cq =13.3 Hz, H-3ax) , 2.319 (IH, dd, J 3κ . 4 =5.9, J 3eq,3ax =13.3 Hz, H-3eq) , 3.805 (3H, s, COOCH 3 ) , 4.073 (IH, dd, ,J 67 =9.5, J 6F =27.8 Hz, H-6) , 4.154 (IH, dd, J 8 ,=3.5, J 8-8 .=12.5 Hz, H-8) , 4.601 (IH, dd, J g 7 =2.2 , J g .. g =12.5 Hz , H-8') , 4.827 (IH, dd, J 54 =2.1, J 5F =50.9 Hz, H-5) , 5.240 (IH, dddd, J 4 . 5 =2.1, J 43eq -=5.9, J 4 . 3ax = 11.5 , J 4F =21.3 Hz, H-4) , 5.288 (IH, ddd, J 7g .=2.2, J 7g =3.5, J 76 =9.5 Hz, H-7) ; I3 C NMR (CDC1 3 ) δ 20.56, 20.56, 20.71, 20.83, 30.60, 53.18, 61.46, 66.45, (d, J CF =17.8 Hz) , 67.89 (d, J CF =4.1 Hz), 69.60 (d, " C . F =18.2 Hz , 83.02 (d, J CF =186.2 Hz), 97.04, 166.49, 167.75, 169.14, 170.18, 170.20. HRMS (M÷Cs + ) calcd C 17 H 23 O n FCs 555.0279, found 555.0288. Example 11 Larger scale synthesis of 18. Fluorosugar 17b (340 mg, 2.25 mmol) , sodium pyruvate (2.074 g, 28.9 mmol) , dithiothreitol (1.7 mg) , NaN 3 (2.3 mg) , phosphate buffer (pH 7.5, 50 mM, 1.12 mL) waε added to the enzyme εolution (3.0 mL, ' 24 U) . After the pH waε adjuεted to 7.5, the volume waε made up to 10.0 mL. The mixture waε εtirred under N 2 at room temperature for 7 days. The pH waε lowered to 2.5 by addition of Dowex 50W-X8 (H + form) and the mixture waε kept at 0°C for 1 h. The precipitate waε removed by centrifugation at 23,000 x g for 1 h at 4°C. Before the anion-exchange reεin treatment, the exceεs pyruvate was removed aε followε. The mixture was diluted to 80 mL and the pH waε adjuεted to 6.5 by the addition of 2N aqueouε ammonia εolution. The antifoam (Antifoam AF emulεion, Dow-Corning Nakaraiteεque, 10% emulεion in water, 0.32 mL) and pyruvate decarboxylaεe (Sigma P 6810, 0.2 mL, 12.5 U) waε added and the mixture waε εtirred at room temperature with bubbling of N 2 (1.5 L/min) . The pH waε monitored and occaεionally adjusted between 6.0 and 6.5, by addition of Dowex 50W-X8 (H + form) . The decarboxylase waε periodically added to the mixture (each 0.2 mL) at an interval of 30 min, to avoid the denaturation which iε cauεed by the rapid formation of acetaldehyde. The total amount of the enzyme waε 3.2 mL (200 U) . The reaction mixture waε further stirred overnight. Then the mixture waε centrifuged, and the supernatant was diluted to 100 mL and applied to a column of Dowex 1-X8 (20-50 mesh, bicarbonate form, bed volume, 100 mL) . The pH of the eluent and washings waε re-adjusted to 5.5 and further applied to the same column to enεure the adsorption of deεired product. After waεhing with water, the deεired product was eluted with a linear gradient from 0 to 0.3 M of ammonium bicarbonate. The product was further purified by Biogel P-2 column (bed volume 20 mL) to give 192 mg (33%) of 18. The Η NMR εpectrum waε identical with the εample mentioned above. Example 12 Benzyl 2,4,5,7,8-penta-0-acetyl-3-deoxy- α-D-jnaiLno-2-octulosonate (20b) . A εuεpenεion of KDO ammonium εalt monohydrate (160 mg, 0.59 mmol) , acetic anhydride (3 mL) , pyridine (3 mL) , and 4- (W,Λ 7 -dimethylamino)pyridine (DMAP, 2 mg) waε εtirred overnight at room temperature. Ice-cooled water waε added and the mixture waε εtirred for 30 min. After dilution with water, the pH of the mixture was adjuεted to 3.5 by addition of Dowex 50W-X8 (H + form). The reεin waε filtered off, and the filtrate waε concentrated in vacuo . The reεidue was diluted with a mixture of chloroform and toluene and the solvent was evaporated. This procedure waε repeated three timeε to remove trace of water. The reεidue waε diεεolved in anhydrouε DMF. Benzyl bromide (161 mg, 0.94 mmol), Cε 2 C0 3 (390 mg, 1.20 mmol) , and tetrabutylammonium iodide (33 mg) were added and the mixture waε εtirred for 4 h at room temperature under N 2 . The mixture waε diluted with 0.5 N ice-cooled hydrochloric acid and extracted twice with a mixture of diethyl ether and toluene (1:1) . The organic layer waε εucceεεively waεhed with water, εaturated aqueouε NaHC0 3 and brine, dried over anhydrouε Na 2 S0 4 and concentrated in vacuo . The residue waε chromatographed over εilica gel (20 g) . Elution with hexane-diethyl ether (2:1-1:1) afforded 15b, which waε recrystallized from diethyl ether to give 220 mg (70%) as colorless plates, mp 102-103°C (lit. 26b mp 98-99°C) ; [α] 26 D +293° (c 1.0, CHC1 3 ) [lit. 26b [α] 5 D +91.9° (c 0.9, CHCl,) . Its Η NMR spectrum (CDC1 3 ) was in good accordance with that reported previously by Naka oto ( Chem . Pharm . Bull . 1987, 35 , 4537) . HRMS (M+Na + ) calcd 561.1584, found 561.1602. Example 13 2,4,5,7,e-Penta-O-acetyl-3-deoxy- α-D-.majmo-2-octulosonic acid (20a) . A mixture of 20b (220 mg, 0.41 mmol) and Pd-C (10%, 55 mg) in ethanol (3 mL) was vigorously stirred under H at room temperature for 1 h. After the catalyst was filtered off, the filtrate was concentrated in vacuo . The residue waε recryεtallized from diethyl ether to give 20a (177 mg, 97%) aε fine needleε, mp 132-133°C; [α] 25 D +374° (c 0.88, CHC1 3 ) . Its l H NMR spectrum (C 6 D 6 ) was identical with that reported previouεly by Unger et al. (Carbohydr . Res . 1980, 80 , 191) . Example 14 ,3,4, 6,7-Penta-0-acetyl-2-deoxy- / 9-D-manno-heptose (21) To a εolution of acid chloride prepared from 20a (30 mg, 0.067 mmol) in toluene waε added dropwiεe a solution of /v-hydroxythiopyridone 22 (11 mg, 0.09 mmol) and DMAP (2 mg) in toluene (0.5 mL) and pyridine (0.3 L) at room temperature under N 2 in the dark. After stirring for 10 min, t-butylmercaptane (0.5 mL) was added and the mixture waε irradiated with white light (tungεten lamp, 100 W) at room temperature. After stirring for 10 min, N 2 was introduced to the mixture under a slightly reduced presεure to remove reεidual t-butylmercaptane for 30 min. Usual workup and purification by silica gel preparative TLC [developed with hexane-Et 2 0 (1:1)] afforded 21 (18.5 mg, 68%) as an oil, [α] 22 D +36.8° (c 1.85, CHCl 3 ) ; Η NMR (CDC1 3 ) δ 2.000-2.150 (2H, m, H-2ax, H-2eq) , 2.010 (6H, ε, acetyl) , 2.082 (3H, ε, acetyl) , 2.119 (3H, ε, acetyl) ' , 2.137 -(3H, s, acetyl) , 3.882 (IH, dd, J 54 =1.5, J 56 =10.0 HZ, H-5) , 4.115 (IH, dd, J r . 6 =4.5 , J r7 =12.5 H, H-7 ' ) , 4.437 (IH, dd, J 7>6 =2.5 , J λr =12.5 Hz, H-7) , 5.073 (IH, ddd, J 34 =3.0, J 3 . 2eq =5.0, J 3 . 2ax =12.5 Hz, H-3) , 5.165 (IH, ddd, J 6 . 7 =2.5, - 6 . 7 .=4.5, J 6 . 5 =10.0 Hz, H-6) , 5.303 (IH, dd, J 45 =1.5, J 4 . 3 =3.0 HZ, H-4) , 5.748 (IH, dd, J eq =3.0, J ax =10.0 HZ, H-l) ; 13 C NMR (CDC1 3 ) δ 20.59, 20.59, 20.65, 20.65, 20.84, 30.35, 62.26, 63.84, 67.32, 67.90, 71.62, 91.67, 168.60, 169.60, 169.83, 170.30, 170.54. HRMS (M+Cε + ) calcd C I7 H 24 O π Cε 537.0373, found 537.0359. Example 15 4-Acetamido-l,3,6,7,8-Penta-0-acetyl-2,4-dideoxy- α-D-glycerc—D-galacto-octose (2 . ) . A 25 mL two-necked flaεk equipped with septum, micro-εcale Dean-Stark trapp which waε filled with molecular εieveε 4A, and a reflux condenεer, waε used aε the reaction veεεel. A mixture of 23a (35.0 mg, 0.07 mmol), DMAP (12.3 mg, 1.5 eq) , 22 (41.0 mg, 5.0 eq) , triethylamine (19 μL) in CH 2 C1 2 (1 mL) waε placed in the flaεk aε above. To thiε waε εucceεεively added a εolution of SCI-C1 (20 mg) in CH 2 C1 2 (1 mL) and t-butylmercaptane (0.5 mL) . The mixture waε εtirred and irradiated with white light (tungεten lamp, 100 ) at room temperature for 5 h. The reaction was worked up in a similar manner as described above. The crude product was purified by silica gel preparative TLC [developed with ethyl acetate-tetrahydrofuran (1:1)] to give 24 (8.7 mg, 27% from 23a) aε an oil, [α] 2 D +21.3° (c 2.87, CHC1 3 ) ; Η NMR (CDC1 3 ) δ 1.908 (3H, ε, N-acetyl) , 1.915 (IH, ddd, J 2ax .,=10.3, J 2ax . 3 =ll.5, J 2ΛX . 2tq =^ 2 • Hz / H-2ax) , 2.043 (3H, ε, O-acetyl) , 2.051 (3H, s, O-acetyl) , 2.102 (3H, ε, O-acetyl) , 2.107 (3H, ε, O-acetyl) , 2.134 (3H, s, O-acetyl) , 2.219 (IH, ddd, Hz, H-2eq) , 3.764 (IH, dd, " J6 =2.4, J, 4 =10.4 Hz, H-5) , 4.023 (IH, dd, J g7 =5.5 , J g . 8 .= 12.6 HZ, H-8) , 4.062 (IH, ddd, J 4NH =10.0, J 43 =10.3, J 4J =10.4 Hz, H-4) , 4.389 (IH, dd, J g . 7 =2.6 , J 8 .. g =12.6 Hz, H-8') , 5.127 (IH, ddd, J 7 . g .=2.6, J 7,g =5.5 , J 7>6 =7.3 Hz , H-7) , 5.058 (IH, ddd, J 3-2cq =4.9 , J 3,4 =10.3 , J 3ι2ax =11.5 Hz, H-3) , 5.190 (IH, d, J NH . 4 =10.0 Hz, NH) , 5.391 (IH, dd, J 6 . 7 =7.3, J 6 . 5 =2.4 Hz, H-6) , 5.646 (IH, dd , J cq =2.1 , J I J X -^0.3 HZ, H-l) ; 13 C NMR (CDC1 3 ) δ 20.70, 20.70, 20.75, 20.83, 20.83, 23.15, 35.09, 49.22, 61.98, 67.11, 70.23, 70.23, 73.67, 91.19, 168.75, 169.90, 170.12, 170.36, 170.59, 170.88. HRMS (M+Cε + ) calcd C 20 H 29 O I2 NCε 608.0744, found 608.0750.

Claims: What iε claimed iε: 1. A purified culture of Aureobacterium barkerei εtrain KDO-37-2. 2. A purified culture of Aureobacterium barkerei εtrain KDO-37-2 as described in claim 1 have a medium employing KDO as a major carbon εource. 3. A purified KDO aldolaεe having εubstrate εpecificitieε with reεpect to multiple aldoεeε for catalytically condensing such aldoseε with pyruvate for forming 2-keto-deoxy-onic acids, the multiple aldoεeε including D-arabinoεe for forming 3-deoxy- D-manno-2-octulεonic acid and D-riboεe for forming 3-deoxy-α-D-altro-2-octuloεonic, the εubεtrate εpecificity with respect to D-riboεe being at leaεt 7% of the εubεtrate specificity with reεpect to D- arabinoεe. 4. A purified KDO aldolaεe aε deεcribed in claim 3 iεolated from Aureobacterium εtrain KDO-37-2. 5. A purified KDO aldolaεe aε deεcribed in claim 3 wherein: K m for the KDO aldolaεe with respect to the condenεation of D-arabinoεe iε approximately 1.2 M. 6. A purified KDO aldolaεe aε deεcribed in claim 5 wherein: V max for the KDO aldolaεe with respect to the condensation of D-arabinose iε approximately 0.73 U/mg. 7. A purified KDO aldolase aε deεcribed in claim 3 wherein: the εubεtrate specificity of said purified KDO aldolase including subεtrateε εelected from the group of aldoseε consisting ■ of D-threose, D- erythroεe, 2-deoxy-D-riboεe, L-glyceraldehyde, D- glyceraldehyde, 2-deoxy-2-fluoro-D-arabinose, D- . lyxoεe, 5-azido-2,5-dideoxy-D-ribose, D-altrose, and L-mannoεe with reεpect to catalytic condenεation with pyruvate to form 2-keto-deoxy- onic acids, the substrate εpecificity with reεpect to any aldoεe within the group being at least 7% of the εubstrate specificity with respect to D- arabinoεe. 8. A purified KDO aldolaεe aε deεcribed in claim 7 iεolated from Aureobacterium barkerei strain KDO- 37-2. 9. A method for synthesizing 2-keto-3-deoxy-onic acids and analogs thereof, the 2-keto-3-deoxy-onic acids being εelected from the group conεisting of 2-keto- 3-deoxy-hexuloεonic acid, 2-keto-3-deoxy- heptulosonic acid, 2-keto-3-deoxy-octulosonic acid, and 2-keto-3-deoxy-nonulosonic acid, the 2-keto-3- deoxy-octuloεonic acid excluding 3-deoxy-D-manno-2- octulεonic acid, the method compriεing the following εtepε, viz.: Step A: providing a purified KDO aldolase; then Step B: admixing, in an aqueous εolution, a 3-6 carbon aldoεe, exclusive of D-arabinoεe, an exceεε of pyruvate, and a catalytic amount of t-he purified KDO aldolase from said Step A; and then Step C: incubating the admixture of said Step B for condensing the 3-6 carbon aldoεe with the pyruvate for producing the 2-keto-3-deoxy-onic acid. 10. A method for εyntheεizing 2-keto-3-deoxy-onic acidε and analogε thereof aε deεcribed in claim 9, wherein: in εaid Step B, the 3-6 carbon aldose being selected in said Step A: the purified KDO aldolaεe being iεolated from Aureobacterium barkerei εtrain KDO-37-2. 11. A method for εynthesizing 2-keto-3-deoxy-onic acids and analogs thereof aε deεcribed in claim 9, wherein: in εaid Step B, the 3-6 carbon aldose being εelected from the group conεiεting of D- threoεe, D-erythroεe, D-ribose, 2-deoxy-D- ribose, L-glyceraldehyde, D-glyceraldehyde, 2- deoxy-2-fluoro-D-arabinoεe, D-lyxoεe, 5-azido- 2,5-dideoxy-D-riboεe, D-altrose, and L-mannose. 12. A method for εyntheεizing a 2-keto-3-deoxy-onic acid as described in claim 9, wherein: in said Step B, the 3-6 carbon aldose having an R-configuration at position C-3. 13. A method for εyntheεizing 3-deoxy-α-D-altro-2- octuloεonic acid aε deεcribed in claim 9, wherein: in εaid Step B, the 3-6 carbon aldoεe iε D- ribose. 14. A method for syntheεizing 3,5-dideoxy-α-D-manno-2- octulosonic acid as deεcribed in claim 9, wherein: in εaid Step B, the 3-6 carbon aldoεe iε deoxy-D- ribose. 15. A method for synthesizing 3-deoxy-α-D-arabino-2- heptulosonic acid as described in claim 9, wherein: SU • r X 1TUTE SHEET (RULE 26) in εaid Step B, the 3-6 carbon aldose iε D- erythroεe. 16. A method for εyntheεizing 3-deoxy-α-D-threo-2- hexuloεonic acid aε deεcribed in claim 9, wherein: in said Step B, the 3-6 carbon aldose iε D- glyceraldehyde. 17. A method for εyntheεizing 3-deoxy-α-D-lyxo-2- heptoloεonic acid aε deεcribed in claim 9, wherein: in εaid Step B, the 3-6 carbon aldose is D- threoεe. 18. A method for εyntheεizing 3-deoxy-α-L-erythro-2- hexuloεonic acid aε described in claim 9, wherein: in said Step B, the 3-6 carbon aldose is L- glyceraldehyde. 19. A method for εynthesizing 3-deoxy-D-manno-2- octulεonic acid and analogε thereof comprising the following εtepε, viz.: Step A: providing a purified KDO aldolaεe iεolated from Aureobacterium barJerei εtrain KDO-37-2; then Step B: admixing, in an aqeuouε εolution, a catalytic amount of the purified KDO aldolaεe from εaid Step A with D-arabinoεe or an analog thereof and an exceεε of pyruvate; then Step C: incubating the admixture of εaid Step B for condenεing the D-arabinose or its analog with the pyruvate for producing the 3-deoxy-D- manno-2-octulεonic acid with a yield of greater than 50%. 20. A method of εyntheεizing a 7-8 carbon 2-deoxy- aldoεe comprising the following steps: Step A: providing a protected form of 8-9 carbon 2-keto-3-deoxy-onic acid with protected εide groups exclusive of the acid group; then Step B: decarboxylating the protected form of 8-9 carbon 2-keto-3-deoxy-onic acid of said Step A by means of a radical medicated decarboxylation for forming a protected form of the 7-8 carbon 2-deoxy-aldose; and then Step C: deprotecting the protected form of the 7- 8 carbon 2-deoxy-aldoεe of εaid Step B for forming the unprotected 7-8 carbon 2-deoxy- aldose. 21. A εynthetic method as described in claim 18 wherein the 7-8 carbon 2-deoxy-aldoεe iε 2-deoxy-^-D-manno- heptoεe and wherein: in εaid Stepε A and B, the protected 8-9 carbon 2-keto-3-deoxy-onic acid iε 2,4,5,7,8-penta-O- acetyl-3-deoxy-α-D-manno-2-octouloεonic acid. 22. A εynthetic method as described in claim 18 wherein the 7-8 carbon 2-deoxy-aldose iε 4-amido-2,4- dideoxy-^-D-glycero-D-galacto-octoεe and wherein: in said Steps A and B, the protected 8-9 carbon 2-keto-3-deoxy-onic acid is 4-acetamido- 1,3,6,7, 8-penta-0-acetyl-2 ,4-dedeoxy-α-D- glycero-D-D-galacto-octoεe. 23. 2-Keto-3-deoxy-hexuloεonic acid. 24. 2-Keto-3-deoxy-heptuloεonic acid. 25. 2-Keto-3-deoxy-octuloεonic acid, excluεive of 3- deoxy-D-manno-2-octulεonic acid. 26. 2-Keto-3-deoxy-nonuloεonic acid. 27. A KDO aldolase condensation product of an aldose with pyruvate, εaid aldoεe excluding D-arabinoεe. JBST T UTE SHEET (RULE 26)

Inventors: SHEN GWO-JENN, SUGAI TAKESHI, WONG CHI-HUEY, SHEN, GWO-JENN, SUGAI, TAKESHI, WONG, CHI-HUEY
Applicants: SCRIPPS RESEARCH INST, SHEN GWO JENN, SUGAI TAKESHI, WONG CHI HUEY, SHEN, GWO-JENN, SUGAI, TAKESHI, THE SCRIPPS RESEARCH INSTITUTE, WONG, CHI-HUEY
Application year: 1993
Main classification: C12N9
IPC codes: C07H7, C12N9, C12P7, C12P9, C12P19